alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### The People of the State of New York, Respondent, v Gerard J. Ryan, Appellant.

[947 NYS2d 869]

Appeal from an order of the Niagara County Court (Sara S. Sperrazza, J.), entered July 7, 2011. The order determined that defendant is a level three risk pursuant to the Sex Offender Registration Act.

*1693It is hereby ordered that the order so appealed from is unanimously affirmed without costs.

Memorandum: On appeal from an order determining that he is a level three risk pursuant to the Sex Offender Registration Act (Correction Law § 168 *et seq.),*defendant contends that County Court’s upward departure from his presumptive classification as a level two risk to a level three risk is not supported by clear and convincing evidence. Contrary to defendant’s contention, we conclude that the People presented “the requisite clear and convincing evidence ‘that there exist[ ] . . . aggravating . . . factor[s] of a kind, or to a degree, not otherwise adequately taken into account by the [risk assessment] guidelines’ ” *(People v McCollum,*41 AD3d 1187, 1188 [2007], *lv denied*9 NY3d 807 [2007]; *see*Sex Offender Registration Act: Risk Assessment Guidelines and Commentary, at 4 [2006]; *see also People v Howe,*49 AD3d 1302 [2008]).

Initially, we note that, although defendant was not assessed any points under the risk assessment instrument for a prior sex crime, there is clear and convincing evidence that he committed various sex offenses during the summers of 2005 and 2006 that resulted in two separate convictions in different counties. Such concurrent convictions may provide the basis for an upward departure if they are “indicative that the offender poses an increased risk to public safety” (Risk Assessment Guidelines and Commentary, at 14; *see People v Vasquez,*49 AD3d 1282, 1284-1285 [2008]; *see cdso People v Neuer,*86 AD3d 926, 927 [2011], *lv denied 17*NY3d 716 [2011]). There is also clear and convincing evidence that defendant lived a transient lifestyle, traveling between campgrounds *(see People v Briggs,*86 AD3d 903, 905 [2011]) and, indeed, that he committed sex offenses at those campgrounds.

Finally, it appears that the Board of Examiners of Sex Offenders did not consider defendant’s convictions of endangering the welfare of a child in its assessment of points under the risk assessment instrument, inasmuch as that offense does not fall within the definition of a sex offense for registration purposes *(see*Correction Law § 168-a [2]; *People v Brown,*45 AD3d 1123, 1124 [2007], *lv denied*10 NY3d 703 [2008]). Nevertheless, defendant’s convictions of endangering the welfare of a child appear to have been based on his having exposed himself to his stepgrandchildren, and we agree with the court that such conduct was not adequately taken into account by the risk assessment instrument *(see Brown,*45 AD3d at 1124; *see also Vasquez,*49 AD3d at 1283-1285). We thus conclude that the record establishes that “the risk of repeat offense is high and there *1694exists a threat to the public safety” to warrant an upward departure to a level three risk (§ 168-Z [6] [c]). Present — Smith, J.P., Fahey, Peradotto, Lindley and Martoche, JJ.
# National Sickle Cell Awareness Month, 2021

Today, 100,000 Americans live with sickle cell disease (SCD). The genetic disease, named for the sickle-shaped red blood cells it causes, leads to severe pain, serious infections, and organ damage. The severity of SCD varies, with many people facing a shortened life expectancy and a host of recurring, debilitating, and expensive health problems.

This condition also disproportionately affects Black and Brown Americans, with an estimated 1 in 365 Black Americans and 1 in 14,000 Hispanic Americans suffering from it. As President, I am committed to supporting those who have been hit the hardest by SCD. And during National Sickle Cell Awareness month, our Nation reaffirms our commitment to improving the quality of life and health outcomes for all individuals living with SCD.

Our Nation's extraordinary medical professionals and scientists are working tirelessly to find a cure and develop improved treatments for SCD. Recent scientific advances have led to effective approaches for managing SCD and preventing complications, including new drug therapies approved by the Food and Drug Administration. And while current treatments may not be universally effective, researchers continue to improve existing treatments, such as bone marrow transplants that can effectively cure SCD in some patients. The National Institutes of Health (NIH) has continued supporting SCD research, education, and capacity building, including the “Cure Sickle Cell Initiative” to accelerate safe, effective, and scalable gene therapies to cure the disease. As a result of the many advances and medical breakthroughs in genetic therapies and research, we are now closer to finding a cure for all SCD patients.

My Administration is committed to following science, delivering breakthroughs, eliminating health disparities facing communities of color and other underserved communities, and promoting the health and wellness of all Americans.

We will continue our efforts to improve the lives and livelihoods of individuals struggling with SCD by improving access to quality health care, collaborating with our partners in the public and private sectors, adhering to the guidance of scientific experts and researchers, and supporting all families affected by SCD.

This month, we celebrate the progress made in treating Americans suffering from SCD and we stand together to improve the health of those living with this disease.

NOW, THEREFORE, I, JOSEPH R. BIDEN JR., President of the United States of America, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim September 2021 as National Sickle Cell Awareness Month. I call upon the people of the United States to learn more about the progress we are making to reduce the burden of this disease on our fellow Americans.

IN WITNESS WHEREOF, I have hereunto set my hand this thirty-first day of August, in the year of our Lord two thousand twenty-one, and of the Independence of the United States of America the two hundred and forty-sixth.

[FR Doc. 2021-19328

Billing code 3295-F1-P
#### Robert H. Whitney *v.*Pauline F. Whitney

*William J. Butler, for*the appellee (plaintiff).

*Mary V. McCarthy,*for the appellant (defendant).

Argued June 3

decided June 3, 1975

The plaintiff’s motion to dismiss the appeal dated May 6, 1975, from the Superior Court in Hartford County is granted unless the defendant files her brief on or before July 10, 1975.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                       2,465,694
<SECURITIES>                                23,142,885
<RECEIVABLES>                                4,861,501
<ALLOWANCES>                                  (227,112)
<INVENTORY>                                          0
<CURRENT-ASSETS>                            30,645,972
<PP&E>                                       1,502,492
<DEPRECIATION>                                 504,289
<TOTAL-ASSETS>                              32,021,517
<CURRENT-LIABILITIES>                        4,838,906
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        10,722
<OTHER-SE>                                  26,899,649
<TOTAL-LIABILITY-AND-EQUITY>                32,021,517
<SALES>                                     11,014,000
<TOTAL-REVENUES>                            15,319,294
<CGS>                                        1,192,621
<TOTAL-COSTS>                                2,284,840
<OTHER-EXPENSES>                            11,127,976
<LOSS-PROVISION>                               241,540
<INTEREST-EXPENSE>                              29,430
<INCOME-PRETAX>                              1,982,446
<INCOME-TAX>                                  (621,500)
<INCOME-CONTINUING>                          1,360,946
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,360,946
<EPS-PRIMARY>                                     0.14
<EPS-DILUTED>                                     0.14
        

</TABLE>
<PAGE>

                                                                    EXHIBIT 15.1

                 AWARENESS LETTERS OF INDEPENDENT ACCOUNTANTS
                 --------------------------------------------

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549

                                                    Re: OYO Geospace Corporation
                                                        Registration on Form S-8

We are aware that our report dated April 20, 2000, on our review of interim
financial information of OYO Geospace Corporation as of March 31, 2000 and for
the three months and six months ended March 31, 2000 and 1999, and included in
the Company's quarterly report on Form 10-Q for the quarter ended March 31,
2000, is incorporated by reference in the Company's registration statements on
Form S-8 (333-40893 and 333-80003).  Pursuant to Rule 436(c) under the
Securities Act of 1933, this report should not be considered a part of the
registration statement prepared or certified by us within the meaning of
Sections 7 and 11 of that Act.



                                                  /s/ PricewaterhouseCoopers LLP


Houston, Texas
May 9, 2000
<PAGE>   1
                                                                   Exhibit 13.1

SELECTED FINANCIAL DATA

<TABLE>
<CAPTION>
YEAR ENDED DECEMBER 31, 1996                1992    1993    1994     1995     1996
(IN THOUSANDS, EXCEPT PER SHARE DATA)

STATEMENT OF INCOME
====================================================================================
<S>                                       <C>      <C>     <C>      <C>      <C>
NET REVENUES                              $1,567   $3,491  $7,171   $10,512  $15,319
------------------------------------------------------------------------------------
INCOME (LOSS) FROM OPERATIONS               (268)     720   1,354     1,685    1,665
------------------------------------------------------------------------------------
NET INCOME (LOSS)                           (174)     413     712     1,052    1,361
------------------------------------------------------------------------------------
NET INCOME (LOSS) PER SHARE                 (.02)     .06     .09       .13      .14
------------------------------------------------------------------------------------
SHARES USED IN PER SHARE CALCULATIONS     $7,290    7,290   8,256     8,292    9,491
====================================================================================

BALANCE SHEET
====================================================================================
WORKING CAPITAL (DEFICIT)                 $ (319)  $   84  $  537   $ 1,353  $25,807
------------------------------------------------------------------------------------
TOTAL ASSETS                                 744    1,805   4,209     6,289   32,322
------------------------------------------------------------------------------------
LONG TERM LIABILITIES                         10       18      20        99      116
------------------------------------------------------------------------------------
STOCKHOLDERS' EQUITY (DEFICIT)              (388)    (308)     71       856   26,910
====================================================================================
</TABLE>


STOCKHOLDER INFORMATION

STOCK LISTING
The Company's common stock is quoted on the Nasdaq National Market System,
symbol: DOCX.
The following table sets forth, for the periods indicated, the range of high
and low sales prices since the Company completed its initial public offering on
September 20, 1996:

<TABLE>
<CAPTION>
                                High            Low
<S>                           <C>             <C>
September 20, 1996 through    $14.50          $12.00
  September 30, 1996
Fourth quarter ended          $16.38          $ 9.50
  December 31, 1996
</TABLE>
EXHIBIT 10.12.3

Amendment No. 11 (the "Amendment") To
Employment Agreement (the "Employment Agreement") between
Ray Rodriguez ("Employee") and The Univision Network Limited Partnership ("Company")

Employee
and Company agree to amend the Employment Agreement as follows:

1.Term.The Term of the Employment Agreement is extended through December 31,
2007, unless earlier terminated in accordance with the provisions of the Employment Agreement.

2.Salary.The annual Base Salary rate will be Eight Hundred Thousand Dollars ($800,000)
for the annual period from January 1, 2007 through December 31, 2007.

3.Effective Date of Amendment.Upon execution by Employee and Company, this Amendment
will become effective as of December 31, 2004.

4.Other.The Employment Agreement shall be governed by and construed in accordance with
the laws of the State of New York, and the parties hereby consent to the exclusive jurisdiction of the federal and state courts located in New York, New York in any dispute arising from or in
connection with this Employment Agreement. Except as provided in this Amendment, all other terms and conditions in the Employment Agreement will remain in full force and effect, and the Employment
Agreement, as amended hereby, is ratified and confirmed.

|                              |  | THE UNIVISION NETWORK LIMITED PARTNERSHIP
|----------------------------- |  | -----------------------------------------
|                              |  | By:                                      
|/s/RAY RODRIGUEZRay Rodriguez |  |                                          

---
# C_2009243EN.01000301.xml

| 10.10.2009 | EN | Official Journal of the European Union | C 243/3 |
| --- | --- | --- | --- |

10.10.2009

EN

Official Journal of the European Union

C 243/3

---

Non-opposition to a notified concentration

(Case COMP/M.5623 — Bridgepoint/TÜV SÜD/DOGUS/Targets)

(Text with EEA relevance)

2009/C 243/02

On 5 October 2009, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32009M5623. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32009M5623. EUR-Lex is the on-line access to the European law.

---
IN THE SUPREME COURT OF TEXAS

-- -- -- --

NO. 18-0145

MICHELIN NORTH AMERICA,

INC.

v.

MOISES GALLEGOS, ET AL.

§

§

§

§

§

§

Dallas County,

5th District.

March 29, 2019

Petitioner's petition for review, filed herein in the above numbered and styled case,

having been duly considered, is ordered, and hereby is, dismissed.



I, BLAKE A. HAWTHORNE, Clerk of the Supreme Court of Texas, do hereby certify

that the above is a true and correct copy of the orders of the Supreme Court of Texas in the case

numbered and styled as above, as the same appear of record in the minutes of said Court under

the date shown.

It is further ordered that petitioner, MICHELIN NORTH AMERICA, INC., pay all costs

incurred on this petition.

WITNESS my hand and seal of the Supreme Court of Texas, at the City of Austin, this

the 3rd day of April, 2019.

Blake A. Hawthorne, Clerk

By Monica Zamarripa, Deputy Clerk

FILE COPY
#### The People of the State of New York, Respondent, v Theodore Churakos, Appellant.

Judgment unanimously affirmed. Counsel’s application to withdraw granted *(see, People v Crawford,*71 AD2d 38). (Appeal from judgment of Supreme Court, Erie County, Marshall, J.—attempted criminal mischief, third degree.) Present—Doerr, J. P., Boomer, Green and Pine, JJ.
Fourth Court of Appeals

San Antonio, Texas

JUDGMENT

No. 04-14-00769-CV

IN THE INTEREST OF G.C.D., a Child

From the 150th Judicial District Court, Bexar County, Texas

Trial Court No. 2013-PA-00697

Honorable Charles E. Montemayor, Judge Presiding1

BEFORE CHIEF JUSTICE MARION, JUSTICE BARNARD, AND JUSTICE MARTINEZ

In accordance with this court’s opinion of this date, the trial court’s order of termination is 

AFFIRMED. 

We order that no costs be assessed against appellant Father or appellant Mother as both are 

indigent. 

SIGNED April 29, 2015.

_____________________________

Marialyn Barnard, Justice

1 The Honorable Renee Yanta is the presiding judge of the 150th Judicial District Court of Bexar County, Texas. The 

termination order was signed by Associate Judge, Charles E. Montemayor.
# Fourth Court of Appeals

San Antonio, Texas

February 26, 2020

No. 04

- 19

- 00208

- CV

J.K. IVEY

, Appellant

v.

TODD MARQUARDT LAW FIRM

,

Appellee

From the 288th Judicial District Court, Bexar County, Texas

Trial Court No. 2018CI24208 The Honorable Moniq ue Diaz, Judge Presiding



### O R D E R

By order dated May 23, 2019, we abated this appeal upon pro of that appellee filed a voluntary petition for bankruptcy. Tex. R. App. P. 8.2. The appeal and all appellate timelines were suspended, and the appeal was closed for administrative purposes pending a request for

reinstatement or severance. We subsequen tly received notice that appellee’s bankruptcy proceeding was dismissed on November 25, 2019. By order dated January 7, 2020, we reinstated this appeal and set an appellate deadline for appellee’s brief.

On January 20, 2020, we received a Notice of Settlement from appellee’s counsel notifying the court that the parties reached a settlement. However, neither party has filed a motion to voluntarily dismiss this appeal in accordance with Texas Rule of Appellate Procedure

42.1. See Tex. R. A pp. P. 42.1. Appellee’s brief remains due.

Accordingly, we ORDER the parties to file a motion to dismiss this appeal in accordance with Texas Rule of Appellate Procedure 42.1 on or before March 17, 2020

. Id

. If a motion to dismiss pursuant to Texas Rule of Appellate Procedure is not filed, appellee’s brief is due on or

before March 17 , 2020

. If appellee’s brief is not filed, this appeal will be set for submiss ion without an appellee’s brief.

_________________________________ Irene Rios , JusticeIN WITNESS WHEREOF, I have hereunto set my hand and affix ed the seal of the said

court on this 26th day of February, 2020

.

___________________________________ M ichael A. C ruz

, Clerk of Court
FI L ED U.S. COURT OF APPEAL S EL EVENTH CI RCUI T FEB RUARY 17, 2010 J OHN L EY CL ERK [ D O N O T P U B L I S H ]

I N T H E U N I T E D S T A T E S C O U R T O F A P P E A L S

F O R T H E E L E V E N T H C I R C U I T

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ N o

. 0 9

- 1 3 4 3 0 N o n
- A r g u m e n t C a l e n d a r

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ D

. C

. D o c k e t N o

. 9 1

- 0 0 0 1 0

- C R

- C A R

- 5

U N I T E D S T A T E S O F A M E R I C A ,

P l a i n t i f f

- A p p e l l e e ,

v e r s u s

T R O Y L E E B R O W N ,
D e f e n d a n t

- A p p e l l a n t

.

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ A p p e a l f r o m t h e U n i t e d S t a t e s D i s t r i c t C o u r t f o r t h e M i d d l e D i s t r i c t o f G e o r g i a

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ( F e b r u a r y 1 7 , 2 0 1 0 )

B e f o r e T J O F L A T , B A R K E T T a n d W I L S O N , C i r c u i t J u d g e s

.
P E R C U R I A M :

D

. N i c o l e W i l l i a m s , a p p o i n t e d c o u n s e l f o r T r o y L e e B r o w n , h a s f i l e d am o t i o n t o w i t h d r a w o n a p p e a l s u p p o r t e d b y a b r i e f p r e p a r e d p u r s u a n t t o A n d e r s v

.

C a l i f o r n i a , 3 8 6 U

. S

. 7 3 8 , 8 7 S

. C t

. 1 3 9 6 , 1 8 L

. E d

. 2 d 4 9 3 ( 1 9 6 7 )

. O u r i n d e p e n d e n t

r e v i e w o f t h e e n t i r e r e c o r d r e v e a l s t h a t c o u n s e l ’ s a s s e s s m e n t o f t h e r e l a t i v e m e r i t o f

t h e a p p e a l i s c o r r e c t

. B e c a u s e i n d e p e n d e n t e x a m i n a t i o n o f t h e e n t i r e r e c o r d r e v e a l s

n o a r g u a b l e i s s u e s o f m e r i t , c o u n s e l ’ s m o t i o n t o w i t h d r a w i s G R A N T E D , a n d t h e
d i s t r i c t c o u r t ’ s d e n i a l o f B r o w n ’ s 1 8 U

. S

. C

. § 3 5 8 2 ( c ) ( 2 ) m o t i o n i s A F F I R M E D

.

2
EXHIBIT 32.1





CERTIFICATION





As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





In connection with the Annual Report on Form 10-K for the fiscal year ended June 30, 2011 of Integrated BioPharma, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), E. Gerald Kay, the Chief Executive Officer of Integrated BioPharma, Inc.(the "Company"), certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to his knowledge:





(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and





(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended.





A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.






Date:  October 13, 2011
By: /s/ E. Gerald KayE. Gerald KayChief Executive Officer